Support of a ‘top-down’ methodology with Geneious Pro™ was a capability requested by a number of our accounts with NGS projects and plans
Auckland, New Zealand (Vocus) September 1, 2009
New Zealand-based scientific software company Biomatters Ltd, creators of Geneious Pro, and GenomeQuest, the leader in sequence data management (SDM), announce an alliance to offer researchers a landmark “top-down” discovery methodology for next generation sequencing (NGS) projects.
Specifically, the companies will integrate Biomatters’ desktop analysis and visualization software, Geneious Pro™ v4.8, with GenomeQuest 6.0Beta, an SDM platform which allows research organizations to manage and mine their sequence data across a portfolio of projects as well as the world of reference data.
The new integrated product service will allow researchers to perform global mining on their NGS projects to identify areas of interest, complete their local investigations with familiar desktop analysis and visualization tools, and manage their sequence data throughout the process. This world-first combination in bioinformatics gives scientists a powerful and necessary new discovery methodology, allows them to perform all stages of discovery straight from their desktop, and harnesses the power of hundreds of processors for NGS projects.
“Support of a ‘top-down’ methodology with Geneious Pro™ was a capability requested by a number of our accounts with NGS projects and plans”, says Ron Ranauro, CEO of GeneomeQuest. “Geneious Pro™ software is emerging as a global front-runner for genetic sequence analysis and visualization. This alliance makes sense for the direction of our companies and, more importantly, for the fast emerging discovery needs of NGS researchers.”
Both companies share a vision for increasing the ease and speed with which researchers will be able to mine, manage and share sequence data, leading to shorter discovery periods and cost-saving efficiencies. Biomatters CEO, Candace Toner says, “around the world, life science researchers are focusing on getting the best performance from their technology partners. Future joint customers of Biomatters and GenomeQuest will achieve seamless integration to the desktop for all scientists, and provide centralized data and access to common workflow solutions from discovery phase, through to complex analysis and publication.”
The technical launch of the integrated product service is planned for October 2009.
Based in Auckland, New Zealand, Biomatters Ltd. (http://www.biomatters.com) are the creators of the multi-award winning desktop application, Geneious Pro™, now used by customers at over 900 universities and institutions in over 60 countries worldwide. Biomatters, Ltd. is dedicated to providing easy-to-use, superior software through the development of innovative and essential applications that accelerate and simplify biological research. By fully leveraging our core capabilities and enabling complete computational scientific solutions through partnering with global experts, Biomatters provides a complete value-based solution to academic and commercial clients. For more information visit http://www.geneious.com.
GenomeQuest, the leader in sequence data management (SDM) helps genomic researchers and their organizations make great discoveries far faster. Over 160 leading life science companies use GenomeQuest for mission-critical work, including 18 of the top 20 pharmaceuticals.
Using GenomeQuest, organizations improve the performance of their discovery process and broadly prepare for next generation sequencing (NGS). Researchers perform discoveries, manage and share sequence data, and access the world's largest collection of reference databases from a web-browser and personalized dashboard. Bioinformatics managers customize discovery workflows and unify their sequence data environment using the open platform. IT and business managers efficiently scale to broad utilization of next generation sequencing in their discovery operations using the GQ-Engine.
Learn more at http://www.genomequest.com.
Dr. Peter Meintjes
+64 (9) 379 5064